SG Americas Securities’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Sell |
37,475
-2,857
| -7% | -$14.4K | ﹤0.01% | 2047 |
|
|
2025
Q1 | $261K | Buy |
+40,332
| New | +$261K | ﹤0.01% | 2082 |
|
|
2024
Q1 | – | Sell |
-96,431
| Closed | -$970K | – | 3023 |
|
|
2023
Q4 | $970K | Buy |
96,431
+6,980
| +8% | +$70.2K | 0.01% | 929 |
|
|
2023
Q3 | $838K | Buy |
+89,451
| New | +$838K | 0.01% | 1311 |
|
|
2023
Q2 | – | Sell |
-118,317
| Closed | -$2.75M | – | 2846 |
|
|
2023
Q1 | $2.75M | Buy |
118,317
+111,654
| +1,676% | +$2.6M | 0.03% | 455 |
|
|
2022
Q4 | $169K | Sell |
6,663
-4,984
| -43% | -$126K | ﹤0.01% | 2108 |
|
|
2022
Q3 | $225K | Sell |
11,647
-282
| -2% | -$5.45K | ﹤0.01% | 1975 |
|
|
2022
Q2 | $304K | Sell |
11,929
-21,822
| -65% | -$556K | ﹤0.01% | 2162 |
|
|
2022
Q1 | $868K | Buy |
33,751
+30,975
| +1,116% | +$797K | 0.01% | 1345 |
|
|
2021
Q4 | $116K | Sell |
2,776
-57,355
| -95% | -$2.4M | ﹤0.01% | 2711 |
|
|
2021
Q3 | $2.62M | Buy |
60,131
+23,427
| +64% | +$1.02M | 0.01% | 937 |
|
|
2021
Q2 | $1.74M | Sell |
36,704
-5,223
| -12% | -$247K | 0.01% | 1100 |
|
|
2021
Q1 | $2.15M | Buy |
41,927
+18,876
| +82% | +$968K | 0.01% | 894 |
|
|
2020
Q4 | $617K | Buy |
+23,051
| New | +$617K | ﹤0.01% | 1603 |
|
|
2020
Q3 | – | Sell |
-24,614
| Closed | -$1.01M | – | 2924 |
|
|
2020
Q2 | $1.01M | Buy |
+24,614
| New | +$1.01M | 0.01% | 1179 |
|